BCL2L1 and Thrombocytopenia: In addition, the Priault team also transfers the knowledge earned on Bcl-xL deamidation to applied science, and a patent has been filed for the use of Bcl-xL deamidation status to discriminate between central and peripheral causes on thrombocytopenia.